NEW YORK (GenomeWeb News) – WaferGen Biosystems today said that it has "established a relationship" with Integrated DNA Technologies to provide IDT's PrimeTime qPCR primers for SYBR-based gene expression assays.

Financial and other terms of the deal were not announced. WaferGen announced the deal in conjunction with the launch of its MyDesign open-format, high-throughput qPCR platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.